(Q41527338)

2 October 2017

1 reference

title

High-dose cytosine arabinoside in the treatment of acute myeloid leukaemia (English)

1 reference

2 October 2017

1 reference

1 reference

Cole N

1

1 reference

PubMed ID

9218105

2 October 2017

Gibson BE

series ordinal

2

1 reference

2 October 2017

1 March 1997

1 reference

2 October 2017

7

1 reference

inferred from page(s)

published in

Blood Reviews

1 reference

2 October 2017

11

1 reference

2 October 2017

1

1 reference

2 October 2017

39-45

1 reference

Toxicity of sequential high-dose ARA-C asparaginase treatment in childhood poor risk leukemia

2 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990005-9

7 January 2021

Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without gran

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990005-9

7 January 2021

Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990005-9

7 January 2021

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990005-9

7 January 2021

High-dose cytosine arabinoside intensification for acute nonlymphocytic leukemia in patients over 56 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990005-9

7 January 2021

Treatment and prognostic factors in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990005-9

7 January 2021

Post-remission treatment of acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990005-9

7 January 2021

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990005-9

7 January 2021

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990005-9

7 January 2021

Cytarabine and neurologic toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2897%2990005-9

7 January 2021

10.1016/S0268-960X(97)90005-9

Identifiers

DOI

1 reference

2 October 2017

1 reference

PubMed ID

9218105